These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of Pro(2) modifications on the structural and pharmacological properties of endomorphin-2. Borics A; Mallareddy JR; Timári I; Kövér KE; Keresztes A; Tóth G J Med Chem; 2012 Oct; 55(19):8418-28. PubMed ID: 22957923 [TBL] [Abstract][Full Text] [Related]
4. New endomorphin analogues containing alicyclic beta-amino acids: influence on bioactive conformation and pharmacological profile. Keresztes A; Szucs M; Borics A; Kövér KE; Forró E; Fülöp F; Tömböly C; Péter A; Páhi A; Fábián G; Murányi M; Tóth G J Med Chem; 2008 Jul; 51(14):4270-9. PubMed ID: 18572932 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues. Tömböly C; Kövér KE; Péter A; Tourwé D; Biyashev D; Benyhe S; Borsodi A; Al-Khrasani M; Rónai AZ; Tóth G J Med Chem; 2004 Jan; 47(3):735-43. PubMed ID: 14736254 [TBL] [Abstract][Full Text] [Related]
6. Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2. Li T; Fujita Y; Tsuda Y; Miyazaki A; Ambo A; Sasaki Y; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y J Med Chem; 2005 Jan; 48(2):586-92. PubMed ID: 15658871 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potent μ-opioid agonists. Liu X; Wang Y; Xing Y; Yu J; Ji H; Kai M; Wang Z; Wang D; Zhang Y; Zhao D; Wang R J Med Chem; 2013 Apr; 56(7):3102-14. PubMed ID: 23477419 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of novel endomorphin-2 analogues with N-O turns induced by alpha-aminoxy acids. Wei J; Shao X; Gong M; Zhu B; Cui Y; Gao Y; Wang R Bioorg Med Chem Lett; 2005 Jun; 15(12):2986-9. PubMed ID: 15984054 [TBL] [Abstract][Full Text] [Related]
10. Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties. Fujita Y; Tsuda Y; Li T; Motoyama T; Takahashi M; Shimizu Y; Yokoi T; Sasaki Y; Ambo A; Kita A; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y J Med Chem; 2004 Jul; 47(14):3591-9. PubMed ID: 15214786 [TBL] [Abstract][Full Text] [Related]
11. Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance. Cardillo G; Gentilucci L; Qasem AR; Sgarzi F; Spampinato S J Med Chem; 2002 Jun; 45(12):2571-8. PubMed ID: 12036366 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2). Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of stereoisomeric analogues of endomorphin-2, H-Tyr-Pro-Phe-Phe-NH(2), and examination of their opioid receptor binding activities and solution conformation. Okada Y; Fukumizu A; Takahashi M; Shimizu Y; Tsuda Y; Yokoi T; Bryant SD; Lazarus LH Biochem Biophys Res Commun; 2000 Sep; 276(1):7-11. PubMed ID: 11006073 [TBL] [Abstract][Full Text] [Related]
14. A new class of highly potent and selective endomorphin-1 analogues containing α-methylene-β-aminopropanoic acids (map). Wang Y; Xing Y; Liu X; Ji H; Kai M; Chen Z; Yu J; Zhao D; Ren H; Wang R J Med Chem; 2012 Jul; 55(13):6224-36. PubMed ID: 22724433 [TBL] [Abstract][Full Text] [Related]
15. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series. Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734 [TBL] [Abstract][Full Text] [Related]
16. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists. Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and automated docking of constrained analogues of the opioid peptide H-Dmt-D-Ala-Phe-Gly-NH₂ using the 4- or 5-methyl substituted 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one scaffold. De Wachter R; de Graaf C; Keresztes A; Vandormael B; Ballet S; Tóth G; Rognan D; Tourwé D J Med Chem; 2011 Oct; 54(19):6538-47. PubMed ID: 21870874 [TBL] [Abstract][Full Text] [Related]
18. Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines. Wentland MP; Ye Y; Cioffi CL; Lou R; Zhou Q; Xu G; Duan W; Dehnhardt CM; Sun X; Cohen DJ; Bidlack JM J Med Chem; 2003 Feb; 46(5):838-49. PubMed ID: 12593663 [TBL] [Abstract][Full Text] [Related]
19. Influence of degradation on binding properties and biological activity of endomorphin 1. Szatmári I; Biyashev D; Tömböly C; Tóth G; Mácsai M; Szabó G; Borsodi A; Lengyel I Biochem Biophys Res Commun; 2001 Jun; 284(3):771-6. PubMed ID: 11396969 [TBL] [Abstract][Full Text] [Related]
20. [(35)S]GTPgammaS binding stimulated by endomorphin-2 and morphiceptin analogs. Fichna J; do-Rego JC; Kosson P; Schiller PW; Costentin J; Janecka A Biochem Biophys Res Commun; 2006 Jun; 345(1):162-8. PubMed ID: 16677613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]